nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—Activation of TRKA receptors—NGF—atopic dermatitis	0.00905	0.192	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—RELB—atopic dermatitis	0.00243	0.0515	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—CXCR3—atopic dermatitis	0.00159	0.0338	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—IL1B—atopic dermatitis	0.00134	0.0284	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00129	0.0274	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—NPS—atopic dermatitis	0.00127	0.0269	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00115	0.0244	CbGpPWpGaD
Regadenoson—Erythema—Triamcinolone—atopic dermatitis	0.0011	0.00116	CcSEcCtD
Regadenoson—Erythema—Methylprednisolone—atopic dermatitis	0.0011	0.00116	CcSEcCtD
Regadenoson—Asthenia—Tacrolimus—atopic dermatitis	0.0011	0.00115	CcSEcCtD
Regadenoson—Acute coronary syndrome—Prednisone—atopic dermatitis	0.0011	0.00115	CcSEcCtD
Regadenoson—Angioedema—Prednisolone—atopic dermatitis	0.0011	0.00115	CcSEcCtD
Regadenoson—Myocardial infarction—Prednisone—atopic dermatitis	0.00109	0.00115	CcSEcCtD
Regadenoson—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.00109	0.00114	CcSEcCtD
Regadenoson—Malaise—Prednisolone—atopic dermatitis	0.00108	0.00114	CcSEcCtD
Regadenoson—Dysgeusia—Triamcinolone—atopic dermatitis	0.00108	0.00113	CcSEcCtD
Regadenoson—Syncope—Prednisolone—atopic dermatitis	0.00108	0.00113	CcSEcCtD
Regadenoson—Eye disorder—Dexamethasone—atopic dermatitis	0.00108	0.00113	CcSEcCtD
Regadenoson—Eye disorder—Betamethasone—atopic dermatitis	0.00108	0.00113	CcSEcCtD
Regadenoson—Angioedema—Hydrocortisone—atopic dermatitis	0.00107	0.00112	CcSEcCtD
Regadenoson—Malaise—Hydrocortisone—atopic dermatitis	0.00106	0.00111	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisolone—atopic dermatitis	0.00105	0.00111	CcSEcCtD
Regadenoson—Syncope—Hydrocortisone—atopic dermatitis	0.00105	0.0011	CcSEcCtD
Regadenoson—Diarrhoea—Tacrolimus—atopic dermatitis	0.00105	0.0011	CcSEcCtD
Regadenoson—Angiopathy—Dexamethasone—atopic dermatitis	0.00104	0.0011	CcSEcCtD
Regadenoson—Angiopathy—Betamethasone—atopic dermatitis	0.00104	0.0011	CcSEcCtD
Regadenoson—Convulsion—Prednisolone—atopic dermatitis	0.00104	0.00109	CcSEcCtD
Regadenoson—Hypertension—Prednisolone—atopic dermatitis	0.00104	0.00109	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00103	0.0219	CbGpPWpGaD
Regadenoson—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.00103	0.00108	CcSEcCtD
Regadenoson—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.00102	0.00107	CcSEcCtD
Regadenoson—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.00102	0.00107	CcSEcCtD
Regadenoson—Bradycardia—Prednisone—atopic dermatitis	0.00102	0.00107	CcSEcCtD
Regadenoson—Convulsion—Hydrocortisone—atopic dermatitis	0.00102	0.00107	CcSEcCtD
Regadenoson—Dizziness—Tacrolimus—atopic dermatitis	0.00101	0.00106	CcSEcCtD
Regadenoson—Hypertension—Hydrocortisone—atopic dermatitis	0.00101	0.00106	CcSEcCtD
Regadenoson—Discomfort—Prednisolone—atopic dermatitis	0.00101	0.00106	CcSEcCtD
Regadenoson—Angioedema—Triamcinolone—atopic dermatitis	0.00101	0.00106	CcSEcCtD
Regadenoson—Angioedema—Methylprednisolone—atopic dermatitis	0.00101	0.00106	CcSEcCtD
Regadenoson—Erythema—Betamethasone—atopic dermatitis	0.001	0.00105	CcSEcCtD
Regadenoson—Erythema—Dexamethasone—atopic dermatitis	0.001	0.00105	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Other—CCR5—atopic dermatitis	0.001	0.0212	CbGpPWpGaD
Regadenoson—Myalgia—Hydrocortisone—atopic dermatitis	0.000998	0.00105	CcSEcCtD
Regadenoson—Malaise—Triamcinolone—atopic dermatitis	0.000995	0.00104	CcSEcCtD
Regadenoson—Anxiety—Hydrocortisone—atopic dermatitis	0.000994	0.00104	CcSEcCtD
Regadenoson—Malaise—Methylprednisolone—atopic dermatitis	0.000993	0.00104	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000991	0.00104	CcSEcCtD
Regadenoson—Syncope—Triamcinolone—atopic dermatitis	0.00099	0.00104	CcSEcCtD
Regadenoson—Syncope—Methylprednisolone—atopic dermatitis	0.000988	0.00104	CcSEcCtD
Regadenoson—Discomfort—Hydrocortisone—atopic dermatitis	0.000986	0.00103	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CCL22—atopic dermatitis	0.000985	0.0209	CbGpPWpGaD
Regadenoson—Connective tissue disorder—Prednisone—atopic dermatitis	0.000984	0.00103	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00098	0.00103	CcSEcCtD
Regadenoson—Vomiting—Tacrolimus—atopic dermatitis	0.000975	0.00102	CcSEcCtD
Regadenoson—ADORA2A—Monoamine Transport—TNF—atopic dermatitis	0.000971	0.0206	CbGpPWpGaD
Regadenoson—Loss of consciousness—Triamcinolone—atopic dermatitis	0.00097	0.00102	CcSEcCtD
Regadenoson—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000968	0.00102	CcSEcCtD
Regadenoson—Rash—Tacrolimus—atopic dermatitis	0.000967	0.00101	CcSEcCtD
Regadenoson—Dermatitis—Tacrolimus—atopic dermatitis	0.000966	0.00101	CcSEcCtD
Regadenoson—Shock—Prednisolone—atopic dermatitis	0.000964	0.00101	CcSEcCtD
Regadenoson—Cough—Triamcinolone—atopic dermatitis	0.000963	0.00101	CcSEcCtD
Regadenoson—Headache—Tacrolimus—atopic dermatitis	0.000961	0.00101	CcSEcCtD
Regadenoson—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000957	0.001	CcSEcCtD
Regadenoson—Convulsion—Triamcinolone—atopic dermatitis	0.000956	0.001	CcSEcCtD
Regadenoson—Tachycardia—Prednisolone—atopic dermatitis	0.000956	0.001	CcSEcCtD
Regadenoson—Convulsion—Methylprednisolone—atopic dermatitis	0.000954	0.001	CcSEcCtD
Regadenoson—Hypertension—Triamcinolone—atopic dermatitis	0.000953	0.001	CcSEcCtD
Regadenoson—Hypertension—Methylprednisolone—atopic dermatitis	0.000951	0.000998	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000947	0.000994	CcSEcCtD
Regadenoson—Shock—Hydrocortisone—atopic dermatitis	0.000941	0.000988	CcSEcCtD
Regadenoson—Myalgia—Triamcinolone—atopic dermatitis	0.00094	0.000986	CcSEcCtD
Regadenoson—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000938	0.000985	CcSEcCtD
Regadenoson—Myalgia—Methylprednisolone—atopic dermatitis	0.000938	0.000984	CcSEcCtD
Regadenoson—Arthralgia—Methylprednisolone—atopic dermatitis	0.000938	0.000984	CcSEcCtD
Regadenoson—Eye disorder—Prednisone—atopic dermatitis	0.000936	0.000983	CcSEcCtD
Regadenoson—Anxiety—Methylprednisolone—atopic dermatitis	0.000934	0.000981	CcSEcCtD
Regadenoson—Tachycardia—Hydrocortisone—atopic dermatitis	0.000934	0.00098	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000931	0.000977	CcSEcCtD
Regadenoson—Flushing—Prednisone—atopic dermatitis	0.00093	0.000976	CcSEcCtD
Regadenoson—Skin disorder—Hydrocortisone—atopic dermatitis	0.000929	0.000975	CcSEcCtD
Regadenoson—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000929	0.000975	CcSEcCtD
Regadenoson—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000929	0.000975	CcSEcCtD
Regadenoson—Discomfort—Triamcinolone—atopic dermatitis	0.000928	0.000974	CcSEcCtD
Regadenoson—Discomfort—Methylprednisolone—atopic dermatitis	0.000926	0.000972	CcSEcCtD
Regadenoson—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000925	0.000971	CcSEcCtD
Regadenoson—Angioedema—Dexamethasone—atopic dermatitis	0.000915	0.00096	CcSEcCtD
Regadenoson—Angioedema—Betamethasone—atopic dermatitis	0.000915	0.00096	CcSEcCtD
Regadenoson—Nausea—Tacrolimus—atopic dermatitis	0.000911	0.000956	CcSEcCtD
Regadenoson—Angiopathy—Prednisone—atopic dermatitis	0.000909	0.000954	CcSEcCtD
Regadenoson—Immune system disorder—Prednisone—atopic dermatitis	0.000905	0.00095	CcSEcCtD
Regadenoson—Malaise—Dexamethasone—atopic dermatitis	0.000903	0.000948	CcSEcCtD
Regadenoson—Malaise—Betamethasone—atopic dermatitis	0.000903	0.000948	CcSEcCtD
Regadenoson—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000901	0.000945	CcSEcCtD
Regadenoson—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000899	0.000943	CcSEcCtD
Regadenoson—Syncope—Dexamethasone—atopic dermatitis	0.000898	0.000943	CcSEcCtD
Regadenoson—Syncope—Betamethasone—atopic dermatitis	0.000898	0.000943	CcSEcCtD
Regadenoson—Hypotension—Hydrocortisone—atopic dermatitis	0.000894	0.000938	CcSEcCtD
Regadenoson—Shock—Triamcinolone—atopic dermatitis	0.000886	0.00093	CcSEcCtD
Regadenoson—Insomnia—Prednisolone—atopic dermatitis	0.000886	0.00093	CcSEcCtD
Regadenoson—Shock—Methylprednisolone—atopic dermatitis	0.000884	0.000928	CcSEcCtD
Regadenoson—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000881	0.000925	CcSEcCtD
Regadenoson—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00088	0.000924	CcSEcCtD
Regadenoson—Loss of consciousness—Betamethasone—atopic dermatitis	0.00088	0.000924	CcSEcCtD
Regadenoson—Paraesthesia—Prednisolone—atopic dermatitis	0.00088	0.000923	CcSEcCtD
Regadenoson—Tachycardia—Triamcinolone—atopic dermatitis	0.000879	0.000923	CcSEcCtD
Regadenoson—Mental disorder—Prednisone—atopic dermatitis	0.000878	0.000921	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CCL27—atopic dermatitis	0.000878	0.0186	CbGpPWpGaD
Regadenoson—Tachycardia—Methylprednisolone—atopic dermatitis	0.000877	0.000921	CcSEcCtD
Regadenoson—Skin disorder—Methylprednisolone—atopic dermatitis	0.000873	0.000916	CcSEcCtD
Regadenoson—Erythema—Prednisone—atopic dermatitis	0.000872	0.000915	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000872	0.000915	CcSEcCtD
Regadenoson—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000871	0.000914	CcSEcCtD
Regadenoson—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000869	0.000912	CcSEcCtD
Regadenoson—Convulsion—Betamethasone—atopic dermatitis	0.000868	0.000911	CcSEcCtD
Regadenoson—Convulsion—Dexamethasone—atopic dermatitis	0.000868	0.000911	CcSEcCtD
Regadenoson—Insomnia—Hydrocortisone—atopic dermatitis	0.000865	0.000908	CcSEcCtD
Regadenoson—Hypertension—Betamethasone—atopic dermatitis	0.000865	0.000907	CcSEcCtD
Regadenoson—Hypertension—Dexamethasone—atopic dermatitis	0.000865	0.000907	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—NPS—atopic dermatitis	0.000863	0.0183	CbGpPWpGaD
Regadenoson—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000859	0.000902	CcSEcCtD
Regadenoson—Myalgia—Dexamethasone—atopic dermatitis	0.000853	0.000895	CcSEcCtD
Regadenoson—Myalgia—Betamethasone—atopic dermatitis	0.000853	0.000895	CcSEcCtD
Regadenoson—Anxiety—Dexamethasone—atopic dermatitis	0.00085	0.000892	CcSEcCtD
Regadenoson—Anxiety—Betamethasone—atopic dermatitis	0.00085	0.000892	CcSEcCtD
Regadenoson—Discomfort—Betamethasone—atopic dermatitis	0.000842	0.000884	CcSEcCtD
Regadenoson—Discomfort—Dexamethasone—atopic dermatitis	0.000842	0.000884	CcSEcCtD
Regadenoson—Hypotension—Methylprednisolone—atopic dermatitis	0.00084	0.000881	CcSEcCtD
Regadenoson—Pain—Prednisolone—atopic dermatitis	0.000838	0.000879	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000833	0.0177	CbGpPWpGaD
Regadenoson—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000826	0.000867	CcSEcCtD
Regadenoson—Vision blurred—Prednisone—atopic dermatitis	0.000822	0.000863	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000821	0.000861	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000819	0.000859	CcSEcCtD
Regadenoson—Pain—Hydrocortisone—atopic dermatitis	0.000818	0.000859	CcSEcCtD
Regadenoson—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000817	0.000858	CcSEcCtD
Regadenoson—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000817	0.000858	CcSEcCtD
Regadenoson—Insomnia—Triamcinolone—atopic dermatitis	0.000815	0.000855	CcSEcCtD
Regadenoson—Insomnia—Methylprednisolone—atopic dermatitis	0.000813	0.000853	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisone—atopic dermatitis	0.000809	0.000849	CcSEcCtD
Regadenoson—Paraesthesia—Triamcinolone—atopic dermatitis	0.000809	0.000849	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisolone—atopic dermatitis	0.000807	0.000847	CcSEcCtD
Regadenoson—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000807	0.000847	CcSEcCtD
Regadenoson—Shock—Dexamethasone—atopic dermatitis	0.000804	0.000844	CcSEcCtD
Regadenoson—Shock—Betamethasone—atopic dermatitis	0.000804	0.000844	CcSEcCtD
Regadenoson—Dyspnoea—Triamcinolone—atopic dermatitis	0.000803	0.000843	CcSEcCtD
Regadenoson—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000802	0.000841	CcSEcCtD
Regadenoson—Nervous system disorder—Betamethasone—atopic dermatitis	0.000802	0.000841	CcSEcCtD
Regadenoson—Tachycardia—Dexamethasone—atopic dermatitis	0.000798	0.000837	CcSEcCtD
Regadenoson—Tachycardia—Betamethasone—atopic dermatitis	0.000798	0.000837	CcSEcCtD
Regadenoson—Angioedema—Prednisone—atopic dermatitis	0.000797	0.000836	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000793	0.0168	CbGpPWpGaD
Regadenoson—Hyperhidrosis—Betamethasone—atopic dermatitis	0.00079	0.000829	CcSEcCtD
Regadenoson—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.00079	0.000829	CcSEcCtD
Regadenoson—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000788	0.000827	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CCL17—atopic dermatitis	0.000787	0.0167	CbGpPWpGaD
Regadenoson—Malaise—Prednisone—atopic dermatitis	0.000786	0.000825	CcSEcCtD
Regadenoson—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000782	0.000821	CcSEcCtD
Regadenoson—Syncope—Prednisone—atopic dermatitis	0.000782	0.000821	CcSEcCtD
Regadenoson—Urticaria—Prednisolone—atopic dermatitis	0.000778	0.000817	CcSEcCtD
Regadenoson—Pain—Triamcinolone—atopic dermatitis	0.00077	0.000808	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisone—atopic dermatitis	0.000767	0.000804	CcSEcCtD
Regadenoson—Hypotension—Dexamethasone—atopic dermatitis	0.000764	0.000802	CcSEcCtD
Regadenoson—Hypotension—Betamethasone—atopic dermatitis	0.000764	0.000802	CcSEcCtD
Regadenoson—Urticaria—Hydrocortisone—atopic dermatitis	0.00076	0.000798	CcSEcCtD
Regadenoson—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000756	0.000794	CcSEcCtD
Regadenoson—Convulsion—Prednisone—atopic dermatitis	0.000756	0.000793	CcSEcCtD
Regadenoson—Hypertension—Prednisone—atopic dermatitis	0.000753	0.00079	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000745	0.000782	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000745	0.000782	CcSEcCtD
Regadenoson—Arthralgia—Prednisone—atopic dermatitis	0.000742	0.000779	CcSEcCtD
Regadenoson—Myalgia—Prednisone—atopic dermatitis	0.000742	0.000779	CcSEcCtD
Regadenoson—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000742	0.000779	CcSEcCtD
Regadenoson—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000741	0.000777	CcSEcCtD
Regadenoson—Anxiety—Prednisone—atopic dermatitis	0.00074	0.000777	CcSEcCtD
Regadenoson—Insomnia—Dexamethasone—atopic dermatitis	0.000739	0.000776	CcSEcCtD
Regadenoson—Insomnia—Betamethasone—atopic dermatitis	0.000739	0.000776	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000737	0.000774	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000735	0.000771	CcSEcCtD
Regadenoson—Paraesthesia—Dexamethasone—atopic dermatitis	0.000734	0.00077	CcSEcCtD
Regadenoson—Paraesthesia—Betamethasone—atopic dermatitis	0.000734	0.00077	CcSEcCtD
Regadenoson—Discomfort—Prednisone—atopic dermatitis	0.000734	0.00077	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisolone—atopic dermatitis	0.000722	0.000757	CcSEcCtD
Regadenoson—Urticaria—Triamcinolone—atopic dermatitis	0.000716	0.000751	CcSEcCtD
Regadenoson—Urticaria—Methylprednisolone—atopic dermatitis	0.000714	0.000749	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisone—atopic dermatitis	0.000712	0.000747	CcSEcCtD
Regadenoson—Abdominal pain—Methylprednisolone—atopic dermatitis	0.00071	0.000746	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000706	0.000741	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000706	0.000741	CcSEcCtD
Regadenoson—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000705	0.00074	CcSEcCtD
Regadenoson—Shock—Prednisone—atopic dermatitis	0.0007	0.000735	CcSEcCtD
Regadenoson—Pain—Dexamethasone—atopic dermatitis	0.000699	0.000734	CcSEcCtD
Regadenoson—Pain—Betamethasone—atopic dermatitis	0.000699	0.000734	CcSEcCtD
Regadenoson—Nervous system disorder—Prednisone—atopic dermatitis	0.000698	0.000733	CcSEcCtD
Regadenoson—Tachycardia—Prednisone—atopic dermatitis	0.000695	0.000729	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000693	0.0147	CbGpPWpGaD
Regadenoson—Skin disorder—Prednisone—atopic dermatitis	0.000691	0.000726	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisone—atopic dermatitis	0.000688	0.000722	CcSEcCtD
Regadenoson—Asthenia—Hydrocortisone—atopic dermatitis	0.000686	0.00072	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000679	0.0144	CbGpPWpGaD
Regadenoson—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000674	0.000707	CcSEcCtD
Regadenoson—Feeling abnormal—Betamethasone—atopic dermatitis	0.000674	0.000707	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000668	0.000701	CcSEcCtD
Regadenoson—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000668	0.000701	CcSEcCtD
Regadenoson—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000664	0.000697	CcSEcCtD
Regadenoson—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000662	0.000695	CcSEcCtD
Regadenoson—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000655	0.000687	CcSEcCtD
Regadenoson—Urticaria—Dexamethasone—atopic dermatitis	0.000649	0.000681	CcSEcCtD
Regadenoson—Urticaria—Betamethasone—atopic dermatitis	0.000649	0.000681	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000648	0.000681	CcSEcCtD
Regadenoson—Dizziness—Prednisolone—atopic dermatitis	0.000648	0.00068	CcSEcCtD
Regadenoson—Asthenia—Triamcinolone—atopic dermatitis	0.000646	0.000678	CcSEcCtD
Regadenoson—Abdominal pain—Betamethasone—atopic dermatitis	0.000646	0.000678	CcSEcCtD
Regadenoson—Abdominal pain—Dexamethasone—atopic dermatitis	0.000646	0.000678	CcSEcCtD
Regadenoson—Asthenia—Methylprednisolone—atopic dermatitis	0.000645	0.000677	CcSEcCtD
Regadenoson—Insomnia—Prednisone—atopic dermatitis	0.000644	0.000676	CcSEcCtD
Regadenoson—Paraesthesia—Prednisone—atopic dermatitis	0.000639	0.000671	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CCL11—atopic dermatitis	0.000634	0.0134	CbGpPWpGaD
Regadenoson—Dizziness—Hydrocortisone—atopic dermatitis	0.000633	0.000664	CcSEcCtD
Regadenoson—Rash—Prednisolone—atopic dermatitis	0.000618	0.000648	CcSEcCtD
Regadenoson—Dermatitis—Prednisolone—atopic dermatitis	0.000617	0.000648	CcSEcCtD
Regadenoson—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000615	0.000645	CcSEcCtD
Regadenoson—Headache—Prednisolone—atopic dermatitis	0.000614	0.000644	CcSEcCtD
Regadenoson—Vomiting—Hydrocortisone—atopic dermatitis	0.000608	0.000638	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000605	0.0128	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000605	0.0128	CbGpPWpGaD
Regadenoson—Rash—Hydrocortisone—atopic dermatitis	0.000603	0.000633	CcSEcCtD
Regadenoson—Dermatitis—Hydrocortisone—atopic dermatitis	0.000603	0.000632	CcSEcCtD
Regadenoson—Headache—Hydrocortisone—atopic dermatitis	0.000599	0.000629	CcSEcCtD
Regadenoson—Dizziness—Triamcinolone—atopic dermatitis	0.000596	0.000625	CcSEcCtD
Regadenoson—Dizziness—Methylprednisolone—atopic dermatitis	0.000594	0.000624	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000594	0.0126	CbGpPWpGaD
Regadenoson—Feeling abnormal—Prednisone—atopic dermatitis	0.000587	0.000616	CcSEcCtD
Regadenoson—Asthenia—Dexamethasone—atopic dermatitis	0.000586	0.000615	CcSEcCtD
Regadenoson—Asthenia—Betamethasone—atopic dermatitis	0.000586	0.000615	CcSEcCtD
Regadenoson—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000582	0.000611	CcSEcCtD
Regadenoson—Nausea—Prednisolone—atopic dermatitis	0.000582	0.000611	CcSEcCtD
Regadenoson—Vomiting—Triamcinolone—atopic dermatitis	0.000573	0.000601	CcSEcCtD
Regadenoson—Vomiting—Methylprednisolone—atopic dermatitis	0.000571	0.0006	CcSEcCtD
Regadenoson—Nausea—Hydrocortisone—atopic dermatitis	0.000568	0.000596	CcSEcCtD
Regadenoson—Rash—Triamcinolone—atopic dermatitis	0.000568	0.000596	CcSEcCtD
Regadenoson—Dermatitis—Triamcinolone—atopic dermatitis	0.000567	0.000596	CcSEcCtD
Regadenoson—Rash—Methylprednisolone—atopic dermatitis	0.000567	0.000595	CcSEcCtD
Regadenoson—Dermatitis—Methylprednisolone—atopic dermatitis	0.000566	0.000594	CcSEcCtD
Regadenoson—Urticaria—Prednisone—atopic dermatitis	0.000565	0.000593	CcSEcCtD
Regadenoson—Headache—Triamcinolone—atopic dermatitis	0.000564	0.000592	CcSEcCtD
Regadenoson—Headache—Methylprednisolone—atopic dermatitis	0.000563	0.000591	CcSEcCtD
Regadenoson—Abdominal pain—Prednisone—atopic dermatitis	0.000563	0.000591	CcSEcCtD
Regadenoson—Diarrhoea—Dexamethasone—atopic dermatitis	0.000559	0.000587	CcSEcCtD
Regadenoson—Diarrhoea—Betamethasone—atopic dermatitis	0.000559	0.000587	CcSEcCtD
Regadenoson—Dizziness—Betamethasone—atopic dermatitis	0.00054	0.000567	CcSEcCtD
Regadenoson—Dizziness—Dexamethasone—atopic dermatitis	0.00054	0.000567	CcSEcCtD
Regadenoson—Nausea—Triamcinolone—atopic dermatitis	0.000535	0.000562	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.000535	0.0113	CbGpPWpGaD
Regadenoson—Nausea—Methylprednisolone—atopic dermatitis	0.000534	0.00056	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisone—atopic dermatitis	0.000524	0.00055	CcSEcCtD
Regadenoson—Vomiting—Dexamethasone—atopic dermatitis	0.00052	0.000545	CcSEcCtD
Regadenoson—Vomiting—Betamethasone—atopic dermatitis	0.00052	0.000545	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CCR3—atopic dermatitis	0.000517	0.011	CbGpPWpGaD
Regadenoson—Rash—Betamethasone—atopic dermatitis	0.000515	0.000541	CcSEcCtD
Regadenoson—Rash—Dexamethasone—atopic dermatitis	0.000515	0.000541	CcSEcCtD
Regadenoson—Dermatitis—Betamethasone—atopic dermatitis	0.000515	0.00054	CcSEcCtD
Regadenoson—Dermatitis—Dexamethasone—atopic dermatitis	0.000515	0.00054	CcSEcCtD
Regadenoson—Headache—Dexamethasone—atopic dermatitis	0.000512	0.000537	CcSEcCtD
Regadenoson—Headache—Betamethasone—atopic dermatitis	0.000512	0.000537	CcSEcCtD
Regadenoson—Asthenia—Prednisone—atopic dermatitis	0.000511	0.000536	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—PPARA—atopic dermatitis	0.000508	0.0108	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL22—atopic dermatitis	0.000505	0.0107	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000496	0.0105	CbGpPWpGaD
Regadenoson—Diarrhoea—Prednisone—atopic dermatitis	0.000487	0.000511	CcSEcCtD
Regadenoson—Nausea—Betamethasone—atopic dermatitis	0.000485	0.00051	CcSEcCtD
Regadenoson—Nausea—Dexamethasone—atopic dermatitis	0.000485	0.00051	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00048	0.0102	CbGpPWpGaD
Regadenoson—Dizziness—Prednisone—atopic dermatitis	0.000471	0.000494	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—NPS—atopic dermatitis	0.000461	0.00977	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—TAC1—atopic dermatitis	0.000461	0.00977	CbGpPWpGaD
Regadenoson—Vomiting—Prednisone—atopic dermatitis	0.000453	0.000475	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CXCR3—atopic dermatitis	0.000452	0.00958	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL27—atopic dermatitis	0.00045	0.00954	CbGpPWpGaD
Regadenoson—Rash—Prednisone—atopic dermatitis	0.000449	0.000471	CcSEcCtD
Regadenoson—Dermatitis—Prednisone—atopic dermatitis	0.000448	0.000471	CcSEcCtD
Regadenoson—Headache—Prednisone—atopic dermatitis	0.000446	0.000468	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000434	0.00921	CbGpPWpGaD
Regadenoson—Nausea—Prednisone—atopic dermatitis	0.000423	0.000444	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000413	0.00875	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NGF—atopic dermatitis	0.000411	0.00871	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL17—atopic dermatitis	0.000404	0.00856	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000372	0.00789	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL10—atopic dermatitis	0.000365	0.00774	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NFKBIA—atopic dermatitis	0.000339	0.00719	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL11—atopic dermatitis	0.000326	0.0069	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FCER2—atopic dermatitis	0.000321	0.0068	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL5—atopic dermatitis	0.000315	0.00667	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL22—atopic dermatitis	0.000298	0.00633	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000292	0.00619	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCR5—atopic dermatitis	0.000283	0.00601	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000282	0.00598	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL27—atopic dermatitis	0.000266	0.00564	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR3—atopic dermatitis	0.000265	0.00563	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPS—atopic dermatitis	0.000261	0.00552	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000261	0.00552	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000255	0.00541	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL5—atopic dermatitis	0.000242	0.00513	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL17—atopic dermatitis	0.000239	0.00506	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPS—atopic dermatitis	0.000237	0.00501	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TAC1—atopic dermatitis	0.000237	0.00501	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000232	0.00492	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000225	0.00477	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL5—atopic dermatitis	0.00022	0.00466	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—MAPK8—atopic dermatitis	0.000213	0.00451	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KIF3A—atopic dermatitis	0.000213	0.00451	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000206	0.00438	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CMA1—atopic dermatitis	0.000192	0.00408	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL11—atopic dermatitis	0.000192	0.00408	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000188	0.00397	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—STAT6—atopic dermatitis	0.000181	0.00383	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—atopic dermatitis	0.00018	0.00382	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000178	0.00377	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	0.000177	0.00374	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000171	0.00363	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL5—atopic dermatitis	0.000161	0.00342	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR5—atopic dermatitis	0.00016	0.00339	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR3—atopic dermatitis	0.000157	0.00332	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR5—atopic dermatitis	0.000145	0.00308	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NPS—atopic dermatitis	0.00014	0.00296	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TAC1—atopic dermatitis	0.00014	0.00296	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCR3—atopic dermatitis	0.000137	0.0029	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—IL6—atopic dermatitis	0.000136	0.00288	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL5—atopic dermatitis	0.00013	0.00275	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL10—atopic dermatitis	0.000111	0.00235	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	9.68e-05	0.00205	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL5—atopic dermatitis	9.54e-05	0.00202	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL2—atopic dermatitis	9.25e-05	0.00196	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGF—atopic dermatitis	8.83e-05	0.00187	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL8—atopic dermatitis	8.79e-05	0.00186	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR5—atopic dermatitis	8.59e-05	0.00182	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL2—atopic dermatitis	8.4e-05	0.00178	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NFKBIA—atopic dermatitis	7.28e-05	0.00154	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL8—atopic dermatitis	5.19e-05	0.0011	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL2—atopic dermatitis	4.96e-05	0.00105	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—atopic dermatitis	4.94e-05	0.00105	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAPK8—atopic dermatitis	4.57e-05	0.000968	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—atopic dermatitis	2.92e-05	0.000618	CbGpPWpGaD
